Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $116.2800 (11.7%) ($104.6000 - $116.2800) on Mon. Aug. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.63% (three month average) | RSI | 57 | Latest Price | $116.2800(11.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.7% a day on average for past five trading days. | Weekly Trend | LGND declines -1.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(56%) IWC(54%) IWN(51%) | Factors Impacting LGND price | LGND will decline at least -1.315% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-4%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.315% (StdDev 2.63%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $99.46(-14.47%) | 5 Day Moving Average | $107.08(8.59%) | 10 Day Moving Average | $107.77(7.9%) | 20 Day Moving Average | $110.48(5.25%) | To recent high | -15.4% | To recent low | 13.5% | Market Cap | $1.869b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |